Literature DB >> 30859415

Catastrophizing attitude changes after onabotulinumtoxin A treatment in chronic migraine.

Licia Grazzi1, Eleonora Grignani2, Emanuela Sansone3, Alberto Raggi2, Domenico D'Amico3, Frank Andrasik4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30859415     DOI： 10.1007/s10072-019-03816-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  3 in total

1.  Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms.

Authors:  K A Holroyd; J B Drew; C K Cottrell; K M Romanek; V Heh
Journal:  Cephalalgia       Date:  2007-09-04       Impact factor: 6.292

2.  Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.

Authors:  Guy P Boudreau; Brian M Grosberg; Peter J McAllister; Richard B Lipton; Dawn C Buse
Journal:  Int J Gen Med       Date:  2015-02-18

3.  A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.

Authors:  Andrea Negro; Martina Curto; Luana Lionetto; Paolo Martelletti
Journal:  J Headache Pain       Date:  2016-01-21       Impact factor: 7.277
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.